Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: J Autoimmun. 2017 Jul 1;85:20–31. doi: 10.1016/j.jaut.2017.06.006

Figure 1.

Figure 1

Type 1 and type 2 cytokines signaling cascade is dependent on the enzymatic activity of members of the Janus kinase family: JAK1, JAK2, JAK3 and TYK2. These enzymes phosphorylate STATs. First-generation JAK inhibitors (red line) block more than one JAK and consequently, inhibit the effect of several cytokines. Selective JAK inhibitors (green line: JAK1; purple line: JAK3, blue line: TYK2), instead have the potential to limit the activity of only selected cytokines.